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abstract
Recent research in both the basic behavioral pharmacology literature and ap-
plied developmental disabilities literature suggests a relationship between in-
creased aggression and the use of benzodiazepines, specifically anxiolytics. 
The purpose of this review is to tie together the findings on benzodiazepine 
anxiolytics from basic pharmacology research and applied research in devel-
opmental disabilities. the similarities and differences in the research in both 
areas will be reviewed. implications for the treatment of aggression in those 
with developmental disabilities are discussed.
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resumen
la investigación reciente en la literatura sobre farmacología conductual bási-
ca y la literatura aplicada sobre discapacidades de desarrollo sugiere una 
relación entre un incremento de la agresión y el uso de benzodiazepinas, 
específicamente ansiolíticos. El propósito de esta revisión es conectar los 
hallazgos sobre ansiolíticos de benzodiazepina en la investigación básica en 
farmacología y la investigación aplicada en discapacidades de desarrollo. se 
revisarán las semejanzas y diferencias en la investigación en ambas áreas. 
se discutirán las implicaciones para el tratamiento de a agresión en aquellos 
con discapacidades de desarrollo.
palabras clave: benzodiazepina, ansiolítico, castigo, extinción, agresión, 
descapacidades de desarrollo
brIef revIew of basIc and applIed research on 
benzodIazepIne anXIolytIcs: ImplIcatIons for the 
treatment of aGGressIon In developmental dIsabIlItIes 
the benzodiazepine drug class has four primary indicated uses – anxiolytic, 
sedative, hypnotic, and anticonvulsant. this paper focuses on benzodiaz-
epine anxiolytics (there are other drugs with anxiolytic properties that are not 
members of the benzodiazepine class and are not included in this review). 
these anxiolytics are prescribed primarily for the treatment of anxiety disor-
ders; however, there are additional indicated uses for these drugs such as 
in the treatment of alcohol withdrawal, epilepsy, tardive dyskinesia, and for 
preoperative sedation. drugs include but are not limited to: alprazolam (xa-
nax), chlordiazepoxide (librium), clonazepam (Klonopin), diazepam (valium), 
lorazepam (ativan), and oxazepam (serax). these drugs exert their effects 
via the inhibitory gamma-aminobutyric acid (GaBa) neurotransmitter system. 
Specifically, therapeutic effects are observed when both GABA and benzodi-
azepine respectively bind to GaBa a and benzodiazepine receptors simulta-
neously (stahl, 2000). short-term use of these drugs is recommended as the 
potential for abuse, dependency, and withdrawal is high. Given these poten-
tial effects, their use in the general population has decreased. nonetheless, 
they are prescribed for a substantial number of individuals with developmen-
tal disabilities to address behavior problems such as aggression (Kalachnik, 
hanzel, sevenich, & harder, 2002). this trend in use is a concern because of 
the aforementioned side effects but also because of reported possible behav-
ioral side effects (Kalachnik et al., 2002).
the purpose of this paper is twofold. first, we will provide a brief review 
of basic behavioral pharmacology research focusing primarily on the effects 
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of benzodiazepine anxiolytics (from here on referred to as anxiolytics) on re-
sponding in punishment and extinction procedures and a review of the avail-
able applied behavioral research on the effects of anxiolytics on aggression of 
individuals with developmental disabilities. Second, based on the findings in 
these literatures, we provide recommendations regarding the use of anxiolyt-
ics for the treatment of aggression in developmental disabilities. 
a literature search was conducted via eRic, Medline, psychinfo, and 
pubMed using the terms “benzodiazepine”, “anxiolytic”, “punishment”, “anti-
conflict”, “extinction”, “mental retardation”, “developmental disability”, and “ag-
gression”. our search was limited to the english language. additional articles 
were identified from the reference lists of previously identified articles. Only 
those studies that focused solely on benzodiazepine anxiolytics between the 
years of 1995 and 2005 were included in this review. those studies focusing 
on methodology were excluded. 
revIew of basIc research
The most notable finding reported with anxiolytics is the anticonflict effect 
observed during punishment. The term “anticonflict” refers to the increase in 
behavior observed during punishment. that is to say when administered anxi-
olytics, responding suppressed by punishment actually increases while there 
are no increases seen for appetitive responding (Kleven & Koek, 1999). this 
is often referred to as a paradoxical reaction because instead of observing the 
anticipated change in behavior, an altogether different response is observed. 
although some research has demonstrated that chronic administration of 
anxiolytics does not produce tolerance with respect to the anticonflict effect 
(e.g., shumsky & lucki, 1996) other research has suggested that tolerance 
at least for some anxiolytics does develop (e.g., diazepam) (smith & Barrett, 
1997). for persons with a history of punishment for antisocial behaviors, such 
as aggression, this could result in increased social problems.
Kleven and Koek (1999) tested several anxiolytics to determine their anti-
conflict effects on responding in pigeons. Diazepam, alprazolam, chlordiazep-
oxide, and lorazepam in addition to other benzodiazepines, produced dose-
related increases in suppressed responding on a multiple fR30 (food) fR30 
(food+shock). Diazepam produced an anticonflict effect at four doses (0.1, 1, 
10, 100mg/kg), alprazolam at two doses (1, 10mg/kg), and chlordiazepoxide 
and lorazepam at one dose (1mg/kg).
in an attempt to determine what conditions contribute to the increase 
in suppressed responding, Witkin (2002) compared baseline responding 
of rats on a multiple fR30 (food) fR10 (food), multiple fR30 (food) fR10 
(food+shock) (responding maintained at 10% of nonpunished responding), 
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and multiple fR30 (food) fR10 (shock) schedules to responding on a multiple 
fR30 (food) fR10 (food+shock) schedule when on chlordiazepoxide. admin-
istration of chlordiazepoxide (1-17 mg/kg) resulted in a dose-dependent in-
crease in punished responding without any effect on non-punished respond-
ing when compared to the first two baseline conditions. When responding was 
evaluated under a multiple fR30 (food) fR10 (shock) schedule, chlordiaz-
epoxide still increased suppressed responding although, not as high rates of 
responding as the multiple fR30 (food) fR10 (food+shock). however, when 
rats were initially trained under a multiple fR30 (food) fR10 (shock) schedule 
and then tested on an fR10 (shock) schedule, chlordiazepoxide did not af-
fect suppressed responding and actually decreased it at higher doses. this 
may indicate an additive effect of reinforcement and chlordiazepoxide on sup-
pressed responding. that is, when an organism has a history of reinforcement 
for appropriate responding, punishment for responses may be more success-
ful. 
flores & pellón (2000) evaluated the effect of diazepam (0.3, 1, 3, and 
10mg/kg) on punished licking in rats. the researchers paired rats based on 
their licking rates. Within the pair, one rat was designated as a master rat 
and the other yoked. half of the master rats were maintained between 5% 
and 30% of their unpunished licking rates with low amplitude shock (0.05 and 
0.07ma) (low suppression) and the other half were maintained between 50% 
and 75% of unpunished licking rates with higher amplitude shock ( 0.10 and 
0.12ma) (high suppression). yoked rats received the same number and inten-
sity of shock not contingent on licking behavior. diazepam did not affect the 
punished or unpunished responding of the master rats in the low suppression 
condition and decreased licking rates of the yoked rats in the low suppression 
condition in a dose-dependent manner. for the high suppression rats, there 
were increases in punished responding for the master rats at two doses of 
diazepam (0.3 and 1mg/kg) and dose dependent decreases in licking for the 
yoked rats. this might indicate the need for more aversive punishment proce-
dures when diazepam is prescribed in humans.
other studies (e.g., leslie et al., 2005; leslie, shaw, Mccabe, Reynolds, 
& dawson, 2004; Mccabe et al., 2004) have found that those anxiolytics that 
affect GaBa systems (e.g., benzodiazepines) can make behavior more or 
less resistant to extinction contingent on when the drug is administered. for 
example, in mice, if the drug is administered solely during the extinction phase 
the behavior is resistant to extinction. however, if the drug is administered 
during a partial reinforcement schedule, which is then followed by extinction, 
extinction seems to occur more quickly, suggesting that the drug may make 
organisms more sensitive to reinforcement, thereby increasing the discrimi-
nation between reinforcement and extinction.
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it was also found that diazepam affects choice. in one study, rats were 
given a choice between two schedules. on one lever, immediate responding 
resulted in the delivery of a small reinforcer. on the second lever, delayed 
responding resulted in the delivery of a larger reinforcer. Researchers found 
that administering the benzodiazepine diazepam increased responding on 
the delayed scheduled for larger reinforcers (evenden & Ryan, 1996).
finally, research has evaluated the effects of benzodiazepines on ag-
gression. pietras and colleagues (2005) evaluated the effects of lorazepam 
on aggressive responding of humans and found that for a majority of their 
participants, lorazepam decreased aggressive responding (this paradigm in-
volved the use of monetary-reinforced responses, escape responses, and an 
aggressive response). For one participant, however, a significant increase in 
aggressive responding was observed to occur. 
the effects of diazepam on high and low aggressors have also been 
examined using female pigeons. at baseline pigeons were characterized as 
either high or low aggressors based on behavior demonstrated during interac-
tions with novel intruders. after eight days of subchronic diazepam adminis-
tration, a food competition was conducted. those pigeons who had engaged 
in high baseline levels of aggression experienced significant decreases in 
aggressive behavior; however, those pigeons who had engaged in low-levels 
of aggression during baseline experienced significantly higher levels of ag-
gression. 
taken together, research on the effects of benzodiazepines on aggressive 
responding supports previous findings that benzodiazepines can decrease 
aggressive responding for most; but for some, an idiosyncratic increase in 
aggression can be observed. it is still unclear, however, what factors might 
be responsible for observed increases in aggression associated with benzo-
diazepine use. 
revIew of applIed research
Well-controlled applied research on the use of anxiolytics in developmental 
disabilities is not as extensive as with animals and provides mixed results re-
garding the effectiveness for treating aggression (see Kalachnik et al., 2002). 
nonetheless, these drugs are often prescribed to address psychiatric issues 
and behavior problems (e.g., aggression) in people with developmental dis-
abilities. While aggression is not always a common side-effect of anxiolytics 
in typically developing humans (cherek, steinberg, Kelly, Robinson, & spiga, 
1990) it may be more common in those with developmental disabilities (Ka-
lachnik et al., 2002). persons with mental retardation often respond differently 
to medication than those in the typical population. this may make them more 
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vulnerable to negative behavioral side effects of medication. for persons with 
mental retardation, instead of suppressing aggression, anxiolytics may further 
exacerbate it (antochi, stavrakaki, & emery, 2003). this effect has also been 
referred to as a “paradoxical effect” in the literature. for example, Kalachnik, 
hanzel, sevenich, and harder (2003), described the case of an individual with 
mental retardation who displayed tantrum behavior during a higher percent-
age of intervals while taking clonazepam than after it was discontinued. addi-
tionally, the participant showed a rate-decreasing effect during the withdrawal 
of the drug. 
however, other study results have suggested that anxiolytics might de-
crease aggression. in one study evaluating the effect of multiple treatments 
(behavioral and medical) on aggression and anxiety in a boy with Blood-
injury-injection phobia, hagopian and colleagues (2001) found that the use 
of behavioral interventions in combination with alprozalam resulted in higher 
compliance with more invasive medical techniques. still other studies report 
that anxiolytics have no effect on aggression (neither decrease nor increase 
frequency nor intensity) (e.g., luiselli, Blew, Keane, thibadeau, & holzman, 
2000).
There are no studies that have demonstrated specific mechanisms re-
sponsible for the disparity in responding to these medications, particularly in 
humans with impaired cognitive ability. Based on current information, how-
ever, one might hypothesize that differences might be related to general 
response to behavioral contingencies. for example, in the hagopian et al. 
(2001) study, reinforcement for appropriate responding was available. per-
haps, while aggressive responding is typically punished in society, persons 
with mental retardation may have a less well-established history of reinforce-
ment for appropriate responding. additionally, while there may be this lack 
of reinforcement for appropriate responding, the anxiolytic medication may 
act as an abolishing operation for their history of punishment for aggressive 
responding. 
conclusIon
in this review, we found similarities in the basic and applied literatures. for 
example, paradoxical reactions to benzodiazepines are reported in the basic 
behavioral pharmacological literature and there are references to similar phe-
nomena in the applied literature. Taking into consideration the findings from 
both basic and applied research, there are clear clinical implications when 
using anxiolytics to treat problem behavior such as aggression. 
first, with regards to the use of punishment, given that some anxiolytics 
are known to cause increases in behavior under punishment conditions, we 
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suggest that anxiolytics and punishment procedures not be used together. 
however, if punishment procedures are to be used to treat problem behavior 
in conjunction with anxiolytic use, procedures must be implemented consis-
tently and not with poor fidelity as basic research demonstrates that anxiolyt-
ics may make behavior resistant to low intensity punishment (flores & pellón, 
2000). punishment procedures should also be introduced prior to anxiolytic 
use (Witkin, 2002). Second, the demonstration that benzodiazepines increase 
responding on delayed schedules of reinforcement for larger reinforcers has 
implications for applied work in terms of fading reinforcement. We suggest 
starting benzodiazepines before attempting to decrease the frequency of 
reinforcement delivered and then simultaneously increasing the amount of 
reinforcer delivered while decreasing the reinforcement ratio. additionally, it 
might be beneficial to ensure that the person has a well-established history 
of reinforcement for socially appropriate behaviors that may interfere with the 
potential paradoxical effect of anxiolytics. finally, if extinction procedures are 
to be implemented, anxiolytics may not be the best drug to use since it is as-
sociated with resistance to extinction (leslie et al., 2004; leslie et al., 2005; 
Mccabe et al., 2004). if anxiolytics and extinction are both used, however, the 
anxiolytic should be implemented prior to the implementation of extinction. 
also, the potential “disinhibition effect” associated with benzodiazepine may 
contraindicate their use altogether. 
poling and lesage (1995) noted limited data on the social validity of the 
use of psychotropic medication with individuals with developmental disabili-
ties. By comparing the findings from basic research with applied studies we 
believe we may be able to begin to ascertain which drugs and behavioral inter-
ventions may best address problem behaviors in developmental disabilities. 
That is, by identifying those drugs with specific effects on operant behavior 
in the laboratory, clinicians may be better able to identify treatments that are 
most efficacious for those with developmental disabilities in applied settings.
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